Automated Immunoassay Analyzers Market Size By Product (Immunofluorescence, Chemiluminescence, ELISA, Enzyme Linked Fluorescent System, Multiplexed Assay System, Radioimmunoassay), By Application (Infectious Diseases, Endocrinology, Drug Monitoring, Cardiology, Oncology, Allergy Testing), By End-use (Hospitals, Diagnostic Laboratories, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024

Published Date: Jan 2019  |  Report ID: GMI1727  |  Authors: Sumant Ugalmugle

Report Format: PDF   |   Pages: 200   |   Base Year: 2017

Summary Table of Contents Industry Coverage Methodology

Industry Trends

Automated Immunoassay Analyzers Market size was valued over USD 9.1 billion in 2017 and is expected to witness more than 16.0% CAGR from 2018 to 2024.

The automated immunoassay analyzers market is set to flourish owing to the growing shift in trend towards lab automated coupled with increasing prevalence of infectious diseases. These products are gaining popularity due to incremental innovation to the existing products and extended clinical applications. Hence, increase in applications of automated immunoassay analyzers will result in growing demand and adoption rate, fueling the market growth.

Automated immunoassay analyzers market

Get more details on this report - Request Free Sample PDF

Recent trends of automation and integration has led to introduction of innovative products in the market, thus driving the market. Various pharmaceutical and biotechnology companies are increasingly using them for drug discovery purposes. Industry players are competing on the basis immunoassay system features, throughput, and menu expansion to capture business share by gaining access to hospitals and laboratories.

Lack of skilled professionals and labor force will be one of the major market impeding factor. The growing healthcare need across the globe hindered by the unavailability of required healthcare personals in the underdeveloped or developing regions. Also, stringent regulatory requirements and high cost involved in transitioning from conventional to automated instruments should hinder the industry growth.

Automated Immunoassay Analyzers Market, By Product

Germany automated immunoassay analyzers market by product

Get more details on this report - Request Free Sample PDF

Chemiluminescence immunoassay analyzers market held the largest revenue share in 2017 and was valued around USD 2,901.0 million. The largest share is attributed to increasing use due to its high sensitivity, and accuracy of analyte detection resulting in accurate diagnosis. The higher receptiveness and veracity of chemiluminescence immunoassay propels the growth prospects for the automated immunoassay analyzers market.

Automated enzyme-linked immunosorbent assay (ELISA) systems market is slated to witness robust growth at a CAGR of 15.9% over the projection period. It is expected to witness healthy growth owing to its extensive test menu at a relatively affordable cost. Moreover, mushrooming use of immunoassay tests in cancer, infectious disease testing, point-of-care in vitro diagnostics and therapeutic drug level monitoring are the factors accounting for upswing in the ELISA segment.

Automated Immunoassay Analyzers Market, By Application

Infectious diseases held the largest automated immunoassay analyzers market share in 2017 and was valued around USD 2,688.8 million. Increasing incidence of infectious diseases in the developing countries fueled business growth. For instance, pneumonia causes 1 in 5 deaths in children below five years of age globally, estimating to nearly 2 million deaths every year. Hence, growing number of people suffering from infectious diseases will result in increase in demand and adoption rate of automated immunoassay analyzers, boosting the market growth.

Cardiology is estimated to witness robust growth at a CAGR of 17.6% over the forecast years owing to the adoption of in cardiac marker testing for prevention of cardiovascular diseases. Rising incidence of cardiovascular disorders and increasing demand for minimally invasive treatment procedures should fuel industry growth. Soaring adolescent populations which are at elevated risk of growth of endocrine gland as a result of imbalance in hormones and spiraling prevalence of diabetes are the paramount factors impelling to drive the business growth.

Automated Immunoassay Analyzers Market, By End-user

Use of automated immunoassay analyzers in hospitals accounted for the largest revenue of USD 3,125.1 million in the year 2017. The high share of hospital was due to consolidation trend among hospitals leading to high test volumes, and favorable health reforms to provide better hospital care. Moreover, increasing number of corporate hospital chains should also boost automated immunoassay analyzers market demand over the forecast years. Diagnostic laboratories should witness highest growth over the forecast years, owing to the rising number of diagnostic laboratories. The use of automated systems helps laboratories to use their skilled resources for more important activities such as analysis and test results review.

Use of automated immunoassay analyzers in diagnostic laboratories is estimated to show considerable amount of growth at a CAGR of 16.6% over the forecast time period.  The use of automated systems helps laboratories to use their skilled resources for more important activities such as analysis and test results review. Apart from this, large corporate diagnostic laboratories are witnessing trend of expanding to remote areas by acquiring smaller diagnostic laboratories with minimal infrastructure. Hence, several applications of automated immunoassay analyzers will boost the business growth in the near future.

Automated Immunoassay Analyzers Market, By Region

Europe automated immunoassay analyzers market by country

Get more details on this report - Request Free Sample PDF

U.S. dominated the North America automated immunoassay analyzers market in the year 2017 and was valued around USD 3,206.5 million. The automation in laboratory significantly reduces the cost and time required for laboratory operations owing to that automated devices in laboratories are increasingly preferred in United States. Increasing adoption rates for lab automation technologies will have positive influence on the growth of U.S. automated immunoassay analyzers market in the forthcoming years.

China automated immunoassay analyzers market is estimated to witness significant growth at a CAGR of 18.8% during the projection period. Favorable government initiatives such as implementation of national project in 2008, aimed at improving the prevention and control of infectious diseases will influence China automated immunoassay analyzers market.

Competitive Market Share

Some of the notable automated immunoassay analyzers market participants include Abbott Diagnostics, Biokit, Biomerieux, Luminex Corporation, Roche Diagnostics, and Siemens Healthcare. The major strategy adopted by industry players include launching of technologically advanced innovative products. Industry participants are also focusing on product portfolio expansion to suit the requirements of different laboratory settings in terms of test volumes, assay menu, automation level and budget to stay ahead of the competition.

Automated Immunoassay Analyzers Industry Background

Automated immunoassay analyzers are widely used in clinical laboratories and hospitals to perform biochemical tests aimed at detection and estimation of concentration of substance in the samples. The automated immunoassay analyzers market faces challenges in terms of cost associated in shifting from conventional lab products to automated ones. Small scale laboratories do not quickly adopt to change in instrumentation due to factors such as system revaluation, staff training, standardization of protocol and long purchase processes. However, manufacturers are seeking to introduce budget friendly analyzer systems or offering replacement benefits to generate revenue. The increased focus on multiplex technologies that use peptide and protein arrays by the companies to introduce multi parametric assays systems should further help manufacturers to boost their revenue share.

Frequently Asked Questions (FAQ) :

The market size of automated immunoassay analyzers exceeded USD 9.1 billion in 2017.
The industry share of automated immunoassay analyzers is expected to witness more than 16% CAGR from 2018 to 2024.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Premium Report Details

  • Published Date: Jan 2019
  • Pages: 200
  • Tables: 184
  • Charts / Figures: 10
  • Companies covered: 17
  • Countries covered: 16

Get a report that explains COVID-19 impact on this market, request a free sample now

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X